Neurogenic bladder in patients with traumatic spinal cord injury: Treatment and follow-up

Spinal Cord

Volumn 52, Issue 6, 2014, Pages 462-467

  Yldz, N ^a   Akkoc Y ^b   Erhan, B ^c   Gunduz B ^c   Ylmaz, B ^d   Alaca, R ^d   Gok H ^e   Koklu K ^f   Ersoz M ^f   Cnar E ^b   Karapolat, H ^b   Catalbas N ^a   Bardak, A N ^c   Turna, I ^c   Demir, Y ^d   Gunes S ^e   Alemdaroglu E ^f   Tunc H ^f  

^a PAMUKKALE UNIVERSITY   (Turkey)

^b EGE UNIVERSITY   (Turkey)

^c Istanbul Physical Medicine and Rehabilitation Training and Research Hospital   (Turkey)

^d GULHANE SCHOOL OF MEDICINE   (Turkey)

^e ANKARA UNIVERSITY   (Turkey)

^f MINISTRY OF HEALTH   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

BOTULINUM TOXIN A; DARIFENACIN; OXYBUTYNIN; PROPIVERINE; SOLIFENACIN; TOLTERODINE; TROSPIUM CHLORIDE; CHOLINERGIC RECEPTOR BLOCKING AGENT;

ADULT; ADULT DIAPER; AGED; ARTICLE; ASYMPTOMATIC BACTERIURIA; BACTERIURIA; BLADDER TRAINING; CONDOM CATHETER; CROSS-SECTIONAL STUDY; DISEASE SEVERITY; DRUG USE; FEMALE; FEVER; FOLLOW UP; HUMAN; INDWELLING CATHETER; INTERMITTENT CATHETERIZATION; MAJOR CLINICAL STUDY; MALE; MEDICAL SPECIALIST; MICTURITION; MULTICENTER STUDY; NEUROGENIC BLADDER; PARAPLEGIA; PRIORITY JOURNAL; QUADRIPLEGIA; RETROSPECTIVE STUDY; SPINAL CORD INJURY; SPINAL CORD LESION; URETHRAL CATHETER; URINARY TRACT INFECTION; ADOLESCENT; CLINICAL TRIAL; MIDDLE AGED; PATHOPHYSIOLOGY; QUESTIONNAIRE; SEX DIFFERENCE; SPINAL CORD INJURIES; TREATMENT OUTCOME; URETHRAL CATHETERIZATION; URINARY BLADDER, NEUROGENIC; URINARY TRACT INFECTIONS; YOUNG ADULT;

ADOLESCENT; ADULT; AGED; CHOLINERGIC ANTAGONISTS; CROSS-SECTIONAL STUDIES; FEMALE; FOLLOW-UP STUDIES; HUMANS; INTERMITTENT URETHRAL CATHETERIZATION; MALE; MIDDLE AGED; QUESTIONNAIRES; RETROSPECTIVE STUDIES; SEX FACTORS; SPINAL CORD INJURIES; TREATMENT OUTCOME; URINARY BLADDER, NEUROGENIC; URINARY TRACT INFECTIONS; YOUNG ADULT;

EID: 84902284771     PISSN: 13624393     EISSN: 14765624     Source Type: Journal    
DOI: 10.1038/sc.2014.41     Document Type: Article

References (23)

1. Horstmann M, Schaefer T, Aguilar Y, Stenzl A, Sievert KD. Neurogenic bladder treatment by doubling the recommended antimuscarinic dosage. Neurourol Urodyn 2006; 25: 441-445.
2. Pannek J, Stöhrer M, Blok B, Castro-Diaz D, Del Popolo G, Kramer G et al. Guidelines on Neurogenic Lower Urinary Tract Dysfunction. European Association of Urology ( EAU): Arnhem, The Netherlands, 2011.
3. Cameron AP, Wallner LP, Tate DG, Sarma AV, Rodriguez GM, Clemens JQ. Bladder management after spinal cord injury in the United States 1972 to 2005. J Urol 2010; 184: 213-217.
4. DeVivo MJ, Krause JS, Lammertse DP. Recent trends in mortality and cause of death among persons with spinal cord injury. Arch Phys Med Rehabil 1999; 80: 1411-1419.
5. Ruutu M, Lehtonen T. Urinary tract complications in spinal cord injured patients. Ann Chir Gynaecol 1984; 73: 325.
6. Penders J, Huylenbroeck AA, Everaert K, Van Laere M, Verschraegen GL. Urinary infections in patients with spinal cord injury. Spinal Cord 2003; 41: 549-552.
7. Savic G, Short DJ, Weizenkamp D, Charlifue S, Gardner BP. Hospital readmissions in people with chronic spinal cord injury. Spinal Cord 2000; 38: 371-377.
8. Kirshblum SC, Burns SP, Biering-Sorensen F, Donovan W, Graves DE, Jha A et al. International standards for neurological classification of spinal cord injury ( Revised 2011). J Spinal Cord Med 2011; 34: 535-546.
9. Levi R, Hultling C, Nash MS, Seiger A. The Stockholm spinal cord injury study: 1. Medical problems in a regional SCI population. Paraplegia 1995; 33: 308-315.
10. Dahlberg A, Perttila I, Wuokko E, Ala-Opas M. Bladder management in persons with spinal cord lesion. Spinal Cord 2004; 42: 694-698.
11. Weld KJ, Graney MJ, Dmochowski RR. Differences in bladder compliance with time and associations of bladder management with compliance in spinal cord injured patients. J Urol 2000; 163: 1228.
12. Hansen RB, Biering-Sorensen F, Kristensen JK. Urinary incontinence in spinal cord injured individuals 10-45 years after injury. Spinal Cord 2010; 48: 27-33.
13. Biering-Sorensen F, Nielans HM, Dorflinger T, Sorensen B. Urological situation five years after spinal cord injury. Scand J Urol Nephrol 1999; 33: 157-161.
14. Sekar P, Wallace DD, Waites KB, DeVivo MJ, Lloyd LK, Stover SL et al. Comparison of long-term renal function after spinal cord injury using different urinary management methods. Arch Phys Med Rehabil 1997; 78: 992-997.
15. Bakke A, Digranes A, Hoisaeter PA. Physical predictors of infection in patients with clean intermittent catheterization: a prospective 7-year study. Br J Urol 1997; 79: 85-90.
16. El-Masri WS, Chong T, Kyriakider AE, Wang D. Long-term follow-up study of outcomes of bladder management in spinal cord injury patients under the care of The Midlands Centre for Spinal Injuries in Oswestry. Spinal Cord 2012; 50: 14-21.
17. Kessler TM, Bachmann LM, Minder C, Löhrer D, Umbehr M, Sc hünemann HJ et al. Adverse event assessment of antimuscarinics for treating overactive bladder: a network meta-analytic approach. PLoS One 2011; 6: e16718.
18. Khanna CR, Sandhu AS, Doddamani CD. Urodynamic management of neurogenic bladder in spinalcord injury. Med J Armed Forces India 2009; 65: 300-304.
19. Nosseir M, Hinkel A, Pannek J. Clinical usefulness of urodynamic assessment for maintenance of bladder function in patients with spinal cord injury. Neurourol Urodyn 2007; 26: 228-233.
20. Ehren I, Volz D, Farrelly E, Berglund L, Brundin L, Hultling C et al. Efficacy and impact of botulinum toxin A on quality of life in patients with neurogenic detrusor overactivity: a randomised, placebo-controlled, double-blind study. Scand J Urol Nephrol 2007; 41: 335-340.
21. Schurch B, de Seze M, Denys P, Chartier-Kastler E, Haab F, Everaert K et al. Botulinum toxin type a is a safe and effective treatment for neurogenic urinary incontinence: results of a single treatment, randomized, placebo controlled 6-month study. J Urol 2005; 174: 196-200.
22. Del Popolo G, Filocamo MT, Li Marzi V, Macchiarella A, Cecconi F, Lombardi G et al. Neurogenic detrusor overactivity treated with english botulinum toxin a: 8-year experience of one single centre. Eur Urol 2008; 53: 1013-1019.
23. Maynard FM, Glass J. Management of the neuropathic bladder by clean intermittent catheterisation: 5 year outcomes. Paraplegia 1987; 25: 106-110.